PA

Pharmakon Advisors

North America, New York, United States, New York

Description

Pharmakon Advisors is a New York-based investment company that offers financing solutions to commercial stage, biotechnology companies.

Investor Profile

Pharmakon Advisors has made 17 investments, with 3 in the past 12 months and 59% as lead.

Stage Focus

  • Post Ipo Debt (82%)
  • Post Ipo Equity (6%)
  • Series A (6%)
  • Debt Financing (6%)

Country Focus

  • United States (94%)
  • Norway (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Biopharma
  • Life Science
  • Oncology
  • Medical Device
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pharmakon Advisors frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Genoa Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Astia Angels
North America, California, United States, San Francisco
Co-Investments: 1
Athyrium Capital Management LP
North America, New York, United States, New York
Co-Investments: 1
Royalty Pharma
North America, New York, United States, New York
Co-Investments: 1
Blue Leaf Ventures
North America, New York, United States, Manhattan
Co-Investments: 1
VT
North America, Virginia, United States, Roanoke
Co-Investments: 1
Bioventures Investors
North America, Massachusetts, United States, Wellesley
Co-Investments: 1
TF
North America, Maryland, United States, Bethesda
Co-Investments: 1
Chainstay Capital & Advisors
North America, Ohio, United States, Columbus
Co-Investments: 1

Which angels does Pharmakon Advisors often collaborate with?

KL
North America, Ohio, United States, Cleveland
Shared Deals: 1

What are some of recent deals done by Pharmakon Advisors?

Geron

Foster City, California, United States

Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies.

BiopharmaBiotechnologyHealth DiagnosticsOncologyPharmaceutical
Post Ipo DebtNov 7, 2024
Amount Raised: $250,000,000
NovoCure

Jersey, Arkansas, United States

An Oncology Company Pioneering a Novel Therapy for Solid Tumors

BiotechnologyHealth CareMedical DeviceOncology
Post Ipo DebtMay 2, 2024
Amount Raised: $100,000,000
Tarsus Pharmaceuticals

Irvine, California, United States

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

BiopharmaBiotechnologyLife Science
Post Ipo DebtApr 19, 2024
Amount Raised: $75,000,000
BioCryst Pharmaceuticals

Birmingham, Alabama, United States

BioCryst has over 80 employees spread across their two locations in Birmingham, Alabama and Durham, North Carolina.

BiotechnologyClinical TrialsTherapeutics
Post Ipo DebtApr 17, 2023
Amount Raised: $450,000,000
ImmunoGen

Waltham, Massachusetts, United States

ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo DebtApr 6, 2023
Amount Raised: $75,000,000
Insmed

Bridgewater, New Jersey, United States

Insmed is a biopharmaceutical company creating medicine for rare diseases.

BiotechnologyMedicalPharmaceutical
Post Ipo DebtOct 19, 2022
Amount Raised: $500,000,000
UroGen Pharma

New York, New York, United States

UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.

BiopharmaBiotechnologyClinical TrialsLife SciencePharmaceutical
Post Ipo DebtMar 8, 2022
Amount Raised: $100,000,000
Coherus Biosciences

Redwood City, California, United States

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Post Ipo DebtJan 7, 2022
Amount Raised: $100,000,000
Evolus

Irvine, California, United States

Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.

BiotechnologyHealth CarePharmaceutical
Post Ipo DebtDec 14, 2021
Amount Raised: $125,000,000
BRAINBox Solutions

Richmond, Virginia, United States

BRAINBox provides objective evidence of injury and prediction of patient recovery.

BiotechnologyHealth CareWellness
Series ADec 8, 2020
Amount Raised: $23,000,000